10 unknown, 3 completed, 2 recruiting, 2 terminated. 7 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Unknown 4, Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Biomarker: new trials by email Literature Review of Biomarker trials Research Report on Biomarker
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Novel Biomarkers in Early Recognition of Acute Kidney Injury After Orthopedic Operations. Biomarker, RRI measurement - Hip Fractures, Acute Kidney Injury | Unknown | Medical University of Warsaw | 200 | 2022-03-15 | 2022-04-05 | |
| Biomarkers in Perioperative Management Biomarker - Postoperative Complications, Quality of Life | Recruiting | St. Antonius Hospital | 5000 | 2021-10-12 | 2026-04-27 | |
| A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF Decompensation event - Heart Failure (HF) | Completed | Bayer | 169 | 2021-06-17 | 2022-12-02 | |
| Prognostic Value of Plasma Mitochondrial DNA and Cytochrome C After Cardiac Arrest Biomarker - Cardiac Arrest | Unknown | University Medical Centre Ljubljana | 87 | 2019-01-08 | 2023-12-06 | |
| CNS Infections Effect on the Inner Ear Vestibular function, OAE/WBT, Biomarker - CNS Infection, Inner Ear Hearing Loss | Unknown | Nordsjaellands Hospital | 700 | 2017-12-01 | 2018-10-23 | |
| Heparin Binding Protein in Early Sepsis Diagnosis Biomarker - Sepsis, Infection | Not applicable | Completed | Hellenic Institute for the Study of Sepsis | 400 | 2017-09-22 | 2018-10-23 |
| Study of Tumor RNA Disruption Assay™ (RDA) Tumor RNA Disruption Assay™ (RDA) - Breast Neoplasms | Not applicable | Terminated | University of Toronto | 1 | 2015-12-01 | 2017-10-26 |
| Liver Immunosuppression Free Trial Biomarker, Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine - Transplantation, Liver | Phase 4 | Terminated | King's College London | 116 | 2015-10-01 | 2024-03-07 |
| Characterization of Heart Failure With Preserved Ejection Fraction cMR, biomarker - Heart Failure, Preserved Ejection Fraction, Cardiac Fibrosis | Not applicable | Recruiting | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 500 | 2014-12-04 | 2024-02-05 |
| RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). Laboratory test, Medical history and physical examination, BW and height - Rectal Cancer | Phase 2 | Unknown | Clinical Research Support Center Kyush | 110 | 2013-09-01 | 2014-10-31 |
| Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer Hsp90 - Breast Cancer | Not applicable | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 1100 | 2013-04-01 | 2014-12-24 |
| Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer hsp90 - Liver Cancer | Not applicable | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 1100 | 2012-10-01 | 2014-12-24 |
| Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer Hsp90 - Colorectal Cancer | Not applicable | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 1100 | 2012-09-01 | 2014-12-24 |
| Biomarker Study to Diagnose Alzheimer's Disease Biomarker - Alzheimer Disease, Mild Cognitive Impairment | Not applicable | Unknown | Seoul National University Hospital | 90 | 2012-03-01 | 2013-06-11 |
| A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours Biomarker - Advanced Solid Tumors | Unknown | National University Hospital, Singapore | 20 | 2011-05-01 | 2013-06-03 | |
| Biomarker in Lung Diseases biomarker - Lung Diseases | Unknown | Heidelberg University | 120 | 2009-10-01 | 2009-10-14 | |
| PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening All eligible subjects will provide blood for SEPT9 biomarker testing - Colorectal Cancer | Completed | Epigenomics, Inc | 7929 | 2008-06-01 | 2014-08-04 |
Breast Neoplasms (2) · Colorectal Neoplasms (2) · Acute Kidney Injury (1) · Alzheimer Disease (1) · Central Nervous System Infections (1) · Cognitive Dysfunction (1) · Death (1) · Hearing Loss, Sensorineural (1) · Heart Arrest (1) · Heart Failure (1) · Heart Failure, Diastolic (1) · Hip Fractures (1) · Infections (1) · Labyrinth Diseases (1) · Liver Neoplasms (1)
Beijing Protgen Biotechnology Development Co., Ltd. (3) · Bayer (1) · Clinical Research Support Center Kyush (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Epigenomics, Inc (1) · Heidelberg University (1) · Hellenic Institute for the Study of Sepsis (1) · King's College London (1) · Medical University of Warsaw (1) · National University Hospital, Singapore (1) · Nordsjaellands Hospital (1) · Seoul National University Hospital (1) · St. Antonius Hospital (1) · University Medical Centre Ljubljana (1) · University of Toronto (1)
China (3) · Germany (3) · Belgium (1) · Canada (1) · Denmark (1) · Greece (1) · Japan (1) · Netherlands (1) · Poland (1) · Singapore (1) · Slovenia (1) · South Korea (1) · United Kingdom (1) · United States (1)
Alberto Sanchez-Fueyo (1) · Anne Catherine Pouleur (1) · Christian Brandt, MD (1) · David F Ransohoff, MD (1) · Evangelos Giamarellos-Bourboulis, MD, PhD (1) · Felix JF Herth, MD (1) · Jinming Yu, MD (1) · Michael Kreuter, MD (1) · Michael Wandell, PharmD. (1) · Murray Krahn, MD,MSc,FRCPC (1) · Shusen Zhen, MD (1) · Timothy R Church, Ph.D. (1) · Yasunori Emi, MD, PhD (1) · Zhongsheng Tong, MD (1)
PMID 23408352, PMID 24333512, PMID 30086783, PMID 34142256, PMID 38862228, PMID 39077419, PMID 40121452, PMID 40997264, PMID 41495328, PMID 41768076
2014 (1)